Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Dapagliflozin
Dapagliflozin
Mixed data for AZ, BMS diabetes drug in new study
Reuters
Thu, 10/22/09 - 09:25 am
Bristol-Myers Squibb
diabetes
AstraZeneca
Dapagliflozin
Warning: Potential Blockbuster Ahead
Motley Fool
Sat, 10/3/09 - 09:41 am
Bristol-Myers Squibb
AstraZeneca
Dapagliflozin
type 2 diabetes
Bristol-Myers, AstraZeneca say their diabetes drug dapagliflozin succeeded in late-stage study
Yahoo/AP
Fri, 10/2/09 - 10:39 am
Bristol-Myers Squibb
AstraZeneca
diabetes
Dapagliflozin
Novel Diabetes Pill From AstraZeneca, Bristol May Have New Risk
Bloomberg
Thu, 10/1/09 - 07:31 am
diabetes
AstraZeneca
Dapagliflozin
Bristol-Myers Squibb
Dapagliflozin Study Demonstrated Improved Glycemic Control In Type 2 Diabetes Patients Treated With High Doses of Insulin and Common Oral Anti-Diabetic Medicines
Yahoo/Business Wire
Sun, 06/7/09 - 08:55 am
Dapagliflozin
AstraZeneca
Bristol-Myers Squibb
diabetes
Pages
« first
‹ previous
1
2
3